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The Breuer–Hering inﬂation reﬂex is initiated by activation of the slowly adapting pulmonary
stretch receptor afferents (SARs), which monosynaptically activate second-order relay
neurones in the dorsal medullary nucleus of the solitary tract (NTS). Here we demonstrate
that during lung inﬂation SARs release both ATP and glutamate from their central terminals
to activate these NTS neurones. In anaesthetized and artiﬁcially ventilated rats, ATP- and
glutamate-selective microelectrode biosensors placed in the NTS detected rhythmic release
of both transmitters phase-locked to lung inﬂation. This release of ATP and glutamate was
independent of the centrally generated respiratory rhythm and could be reversibly abolished
during the blockade of the afferent transmission in the vagus nerve by topical application of
local anaesthetic. Microionophoretic application of ATP increased the activity of all tested NTS
second-order relay neurones which receive monosynaptic inputs from the SARs. Unilateral
microinjection of ATP into the NTS site where pulmonary stretch receptor afferents terminate
producedcentralapnoea,mimickingtheeffectoflunginﬂation.ApplicationofP2andglutamate
receptor antagonists (pyridoxal-5-phosphate-6-azophenyl-2,4-disulphonic acid, suramin and
kynurenicacid)signiﬁcantlydecreasedbaselinelunginﬂation-inducedﬁringofthesecond-order
relayneurones.ThesedatademonstratethatATPandglutamatearereleasedintheNTSfromthe
centralterminalsofthelungstretchreceptorafferents,activatethesecond-orderrelayneurones
and hence mediate the key respiratory reﬂex – the Breuer–Hering inﬂation reﬂex.
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The central respiratory network located in the medulla
oblongata and pons is responsible for generation of the
respiratory rhythm. The network also includes premotor
neurones which transmit this rhythm to spinal
motorneuronescontrollingthediaphragmandintercostal
muscles (Feldman et al. 2003; Feldman & Del Negro,
2006). The major afferent inputs to the brainstem
respiratory network that inﬂuence its activity originate
from the central and peripheral arterial chemoreceptors
and from the pulmonary stretch receptors that provide
information about the mechanical status of the lungs
and the chest. Activation of slowly adapting pulmonary
stretch receptors (SARs) during lung inﬂation initiates
the Breuer–Hering reﬂex – a key negative feedback
mechano-reﬂex controlling the duration of inspiration
(Breuer, 1868; Head, 1889; Adrian, 1933; Widdicombe,
2001). SARs monosynaptically transmit information
about lung volume to the second order relay neurones
or pump cells located in a discrete region of the dorsal
medullary nucleus of the solitary tract (NTS) at the level
of the area postrema and adjacent to the tractus solitarius
(Bonham & McCrimmon, 1990; Miyazaki et al. 1999;
Kubin et al. 2006). Pump cells relay the information
obtained from SARs to the medullary and pontine
respiratory networks (Ezure et al. 2002; Kubin et al. 2006)
to evoke rapid suppression of inspiratory activity. Several
studies have demonstrated that activation of the pump
cells by the SARs input is at least partly mediated by
the action of glutamate at excitatory amino acid (EAA)
receptors(mostlikelyofAMPAtype)(Bonhametal.1993;
Zhang & Mifﬂin, 1995; Miyazaki et al. 1999; Kubin et al.
2006).
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Speciﬁc ATP receptors, both ionotropic P2X and
metabotropic P2Y, are widely expressed in the CNS by
both neurones and glia. Although there are few central
synapses where fast neurotransmission is predominantly
mediated via release of ATP and activation of post-
synaptic P2X receptors (Edwards et al. 1992; Khakh &
North, 2006; Burnstock, 2007), ATP can be released as a
cotransmitter (Jo & Schlichter, 1999; see Pankratov et al.
2006forreview).Inthecortex(Pankratovetal.2002,2003)
and hippocampus (Pankratov et al. 1998), glutamatergic
EPSCscontainasmallP2Xreceptor-mediatedcomponent
that is mediated through quantal release of ATP
(Pankratov et al. 2007).
ATP receptors are distributed widely throughout the
brainstem and in the NTS the density of neurones and
nerve ﬁbres that contain ionotropic P2X receptors is
remarkably high (Kanjhan et al. 1999; Yao et al. 2000,
2001, 2003). Given the abundance of ATP receptors in
the NTS and the precedent of cotransmssion by ATP
and glutamate, we examined the contribution of ATP
signalling to transmission at the central synapses of the
SARs. First, ATP- and glutamate-selective biosensors were
usedtodeterminewhetherATPandglutamatearereleased
in the NTS during lung inﬂation. Then, the effect of
exogenous ATP on breathing and discharge patterns of
different types of NTS neurones was determined. Finally,
the effects of P2 and EAA receptor antagonists applied
individually or simultaneously on the activity of the NTS
pump cells were examined.
Methods
Surgical procedures
Experimentswereperformedon43maleSprague–Dawley
rats(300–340g)andcarriedoutinaccordancewiththeUK
Animals (Scientiﬁc Procedures) Act, 1986. The rats were
anaesthetized with pentobarbitone sodium (60mgkg−1,
I.P.). Anaesthesia was maintained with supplemental
doses of pentobarbitone sodium injected intravenously
as required (10mgkg−1 h−1). Adequate anaesthesia was
ensured by maintaining stable levels of arterial blood
pressure (ABP), heart and central respiratory rate. The
femoralarteryandveinwerecannulatedformeasurement
of ABP and administration of anaesthetic, respectively.
Thetracheawascannulatedandtheanimalwasventilated
with O2-enriched air using a positive pressure ventilator
with a tidal volume of 1.5–2.0ml and a ventilator
frequency similar to the normal respiratory frequency
(∼60strokesmin−1). The animal was then injected with
gallamine triethiodide (Flaxedil, 10mgkg−1, I.V.; then
1–2mgkg−1 h−1, I.V.) and was placed in a stereotaxic
frame. An occipital craniotomy was performed and the
cerebellum was partially removed to expose the dorsal
surface of the brainstem. The exposed area of the brain
was protected by covering with modiﬁed Bulmer’s buffer,
whichconsistedof(mM):100NaCl,1MgSO4,2KPibuffer ,
5 glycerol (pH7.4).
Activity of the phrenic nerve was recorded as an
indicator of central respiratory drive. The signal was
ampliﬁed(×20000),ﬁltered(500–1500Hz),rectiﬁedand
smoothed (τ =100ms). The vagus nerve was isolated
from the surrounding tissues, placed on silver wire
electrodes for electrical stimulation and covered with
dental impression material. Partial pressures of O2
and CO2 as well as pH of the arterial blood were
measured every 1–2h. End-tidal levels of CO2 were
monitored on-line using a fast-response CO2 analyser
(model Capstar-100, CWE Inc., Ardmore, PA, USA) and
kept at 4–5% by adjusting tidal volume and respiratory
frequency. The body temperature was maintained with a
servo-controlled heating pad at 37.0±0.2◦C.
ATP and glutamate biosensors
The design and operation of the enzyme-based ATP
biosensorsusedin thisstudyhavebeen describedin detail
elsewhere(Llaudetetal.2003,2005;Gourineetal.2005a,b;
Frenguelli et al. 2007). The ATP sensors comprised
two enzymes, glycerol kinase and glycerol-3-phosphate
oxidase, entrapped within a matrix around a ﬁne Pt wire
of 50 or 100μmi nd i a m e t e ra n d1m ml o n g .
The glutamate biosensor contained glutamate oxidase
entrapped within a matrix around Pt wire (diameter
50μm, length 1mm). Glutamate oxidase converts
glutamate to α-ketoglutarate with the production of
NH3 and H2O2. Like the ATP biosensor, the glutamate
sensor thus relies on the amperometric detection of
H2O2 produced within the thin enzymatic layer around
the microelectrode tip. Both the ATP and glutamate
biosensors respond rapidly to changes in analyte
concentration achieving a 10–90% response time of less
than 10s (Fig.1A)( L l a u d e tet al. 2005).
Electrochemical sensors can respond not only to
the analyte of interest, but also to any other electro-
active species in the milieu such as ascorbate, urate
or catecholamine transmitters. The biosensors used in
this study had an internal permselective layer of poly-
phenylenediamine that greatly increased their selectivity
for the analyte of interest versus electroactive species
(Masse et al. 2007; Frenguelli et al. 2007).
Nevertheless, in all experiments we controlled for the
release of these ‘non-speciﬁc’ electroactive interferents by
using a dual recording conﬁguration: in addition to an
ATPorglutamatesensorthatwasinsertedintoonesideof
the medulla, a null sensor lacking enzymes but otherwise
identical in size and shape was inserted into an equivalent
position on the other side of the medulla (Fig.1B).
Sensors were calibrated in vitro immediately prior and
after the recordings (some 1–2h later) to test whether
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they retained sensitivity. During the recordings, ATP and
glutamate sensors lost on average ∼70% and ∼50% of
their initial sensitivities, respectively. To convert changes
in sensor current to changes in analyte concentrations,
the mean of the initial and ﬁnal calibrations was used.
Note that this conversion assumes that the entire surface
are of the sensor is in contact with the sites releasing
ATP and glutamate. This is unlikely to be the case (see
Results) and the concentrations reported below are likely
to substantially underestimate the actual amounts of ATP
and glutamate released. Nevertheless, this presentation
of sensor current in units of concentration allows for
differences in sensitivity between the biosensors.
Measurements of the lung inﬂation-induced changes
in ATP and glutamate concentrations in the NTS
The sensors were connected to a MicroC potentiostat
(WPI,Sarasota,FL,USA)andheldonastereotaxicmicro-
manipulator. The sensors were aligned with the obex and
placed into the NTS sites (0.3–0.5mm rostral, 1.0mm
lateral and 0.6–1.0mm ventral of obex) where central
terminals of pulmonary SARs terminate (Fig.1B and C)
Figure 1. Performance of the glutamate biosensors, sensor placement in the nucleus of the solitary
tract (NTS) and locations of the second order relay neurones which receive monosynaptic inputs from
the slowly adapting pulmonary stretch receptor afferents
A, calibration curve of the glutamate biosensor demonstrating linearity of glutamate detection in concentrations
from 1 μM to 100 μM and an expanded portion of the calibration trace demonstrating the fast response
characteristics of the biosensor. Change-over of the solution in the calibration chamber was not a step change.
It would take a few seconds for glutamate to reach the desired concentration. Note that the sensor responds
immediately when glutamate solution is starting to enter the chamber. B, schematic showing the sensor placement
in the NTS. A dual recording conﬁguration of ATP (or glutamate) sensor placed upon one side of the medulla along
with a null sensor that was placed in an equivalent position on the contralateral side was used (see main text for
details). C, grey area depicts the region from which biosensor recordings were made. D, locations of the 42 pump
cells recorded. The locations of the recording sites were identiﬁed by ionophoretic deposition of Pontamine Sky
Blue dye. XII, hypoglossal nucleus. AP, area postrema. DVN, dorsal motor nucleus of the vagus nerve, S, solitary
tract. Anatomical structures are indicated according to the classiﬁcation of Paxinos & Watson (1986).
(Bonham & McCrimmon, 1990; Wasserman et al. 2000).
The identical placement of the ATP, glutamate sensors
and respective null sensors was achieved by aligning them
to the obex and by means of the vernier scale of the
manipulator. Once the sensors were placed, the exposed
area of the brainstem and both sensors were covered
with modiﬁed Bulmer’s buffer (to provide glycerol for
the operation of the ATP biosensor) and a period of
20–30min was allowed for the biosensors to polarize
to their operating potential (+500mV with respect to
Ag–AgCl).
To determine the nature of the rhythmic signals
recorded by the ATP and glutamate biosensors, the
following tests were performed: (i) induction of central
apnoea by mechanical hyperventilation (reducing blood
and brain levels of PCO2) to determine dependence of the
rhythmic ATP release upon the central respiratory drive;
(ii) reversible blockade of the vagus nerve conductance
(including pulmonary SARs conductance) by topical
application of the local anaesthetic lidocaine (1%) to
determine the dependence of the rhythmic ATP and
glutamatereleasesuponvagalnerveinput;(iii)application
of high concentrations of EAA receptor antagonist
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kynurenic acid (5mM) or GABA (100mM)o nt h e
exposed dorsal surface of the brainstem to determine
the dependence of the signals recorded with the ATP
sensor upon NTS neuronal activities; and (iv) electrical
stimulation of the vagus nerve (1ms pulses, 0.5mA,
100Hz for 250ms) to determine whether it could trigger
release of ATP in the NTS (stimulation of the vagus nerve
at this high frequency is believed to mimic lung inﬂation
inoppositiontolow-frequencystimulationwhichmimics
lung deﬂation (Kato et al. 2004)).
At the end of the experiment the animals were
killed humanely by an overdose of pentobarbitone
sodium (200mgkg−1, I.V.), the brains were removed
and the locations of the recording sites were identiﬁed
histologically and mapped using a stereotaxic atlas
(Paxinos & Watson, 1986). Histological analysis of the
sensor placements conﬁrmed that recording sites were
within the targeted region of the NTS.
Recordings of the NTS neurones
Extracellular single-unit recordings and ionophoretic
application of drugs were made using 5-barrelled micro-
electrodes (tip diameter 1–3μm, resistance 5–15M ).
The recorded signal was ampliﬁed (×10000) and
ﬁltered (0.5–1.5kHz). The recording barrel of the
microelectrode contained NaCl (4 M). The other
barrels of the microelectrode contained ATP (20mM,
pH8.0), P2 receptor blocker suramin (20mM, pH8.0)
or pyridoxal-5 -phosphate-6-azophenyl-2 ,4 -disulphonic
acid (PPADS, 100μM, pH8.0), EAA receptor antagonist
kynurenicacid(100mM,pH8.0)andPontamineSkyBlue
dye (2% in 0.2 M sodium acetate). All the drugs were
retainedinthebarrelsbyapplicationof15nAcurrentand
ejectedusingnegativecurrents.TheconcentrationsofATP,
suraminandPPADShavebeenchosenbasedontheresults
of the previous studies that investigated the effects of
these compounds on the activity of the ventral medullary
respiratoryneurones(Ralevicetal.1999;Thomas&Spyer,
2000; Gourine et al. 2003). All drugs were from Sigma
(Poole, UK).
Pump cells were identiﬁed based on the following
criteria (Ezure et al. 1998; Miyazaki et al. 1998, 1999;
Ezure&Tanaka,2000):(i)dischargepatternphase-locked
to lung inﬂation; (ii) inspiratory inhibition; (iii) slowly
adapting discharge in response to maintained lung
inﬂation; (iv) monosynaptic activation by electrical
stimulation of the ipsilateral vagus nerve (latencies
<3ms). Although not speciﬁcally targeted, other NTS
neurones with rhythmic respiratory-related discharge
were also recorded and their responses to ionophoretic
application of ATP were determined. These included
inspiratory Iβ neurones (identiﬁcation criteria: (i)
discharge during the inspiratory phase of the respiratory
cycle; (ii) monosynaptic activation by electrical
stimulation of the vagus nerve; and (iii) tonic maintained
discharge during lung inﬂation), Iα neurones (the rest
of the NTS neurones with inspiratory-related discharge
which is not affected by lung inﬂation or deﬂation) and
deﬂation-sensitive neurones (Ezure & Tanaka, 2000).
Once a steady ﬁring rate of the neurone had been
established, drugs were applied ionophoretically (Neuro-
phore, Medical Systems Corp., NY, USA). Effects of
ATP, suramin and PPADS applied with the currents
of 25 and 50nA for 40s were determined. The
effects of P2 receptor antagonist suramin and EAA
receptor antagonist kynurenic acid applied individually
or simultaneously on the activity of pump cells were also
recorded and compared. Recording sites were marked
by ionophoretic deposition of Pontamine Sky Blue dye
(500nA; 10min). At the end of the experiment the
animal was terminally anaesthetized with pentobarbitone
sodium(200mgkg−1, I.V.)andwasperfusedtranscardially
with 100ml of heparinized saline followed by 200ml
of 4% paraformaldehyde in 0.1 M phosphate buffer
(pH7.4). Brains were removed, postﬁxed, sectioned
serially (100μm) and counterstained with Neutral Red.
Recording sites were visualized using a light microscope
and mappedusing a stereotaxicatlas (Fig.1D) (Paxinos &
Watson, 1986).
Microinjections into the NTS
The rats were prepared as described above (see Surgical
procedure). A three-barrelled glass micropipette (tip
size 20–25μm )w a sp l a c e di nt h eN T Sr e g i o nw h e r e
SARs terminate (0.3–0.5mm rostral, 1.0mm lateral and
0.6–1.0mm ventral of obex). The barrels of the micro-
pipette contained ATP (20mM, pH7.4), vehicle (aCSF
consisted of (mM): 124 NaCl, 3.3 KCl, 2.4 CaCl2,1 . 3
MgSO4,2 6N a H C O 3,1 . 2K H 2PO4 and 10 D-glucose;
saturated with 95% O2–5% CO2; pH7.4) and Pontamine
Sky Blue dye (2% in 0.2 M sodium acetate). The injections
weremadeusingpressureoveraperiodof5–10sandwere
monitoredusingadissectingmicroscopewithacalibrated
micrometer eyepiece. First, unilateral microinjection of
aCSF (50nl) was made to observe the pressure effect.
Then, the effect of ATP microinjected into the NTS on
baseline respiratory activity was determined. The sites of
microinjections were marked by injection of Pontamine
Sky Blue dye, identiﬁed histologically and mapped using
a stereotaxic atlas (Paxinos & Watson, 1986).
Data analysis
Recordings were processed using a Power 1401 inter-
face and analysed using Spike2 software (Cambridge
Electronic Design, Cambridge, UK). Rhythmic changes
in ATP and glutamate levels are presented as both raw
data and means± S.E.M.of peak (in nM) increases in
concentrations. The amplitude of ATP and glutamate
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signals before and after blockade of the vagus nerve
conductance,kynurenicacidorGABAapplicationsonthe
dorsal surface of the medulla oblongata were compared
using Student’s paired t test. Neuronal single-unit
discharge is expressed as raw data or rate histograms
after discrimination of the activity with a window
discriminator. Baseline ﬁring was assessed by averaging
ﬁring rate during the active phase of the neurone over
10–20 respiratory cycles prior to the application of
drugs. Neuronal discharge frequencies before and during
applications of drugs were compared using Student’s
paired t test. A value of P <0.05 was considered to be
signiﬁcant.
Results
Rhythmic ATP release in the NTS
ATP microelectrode biosensors placed into the area of the
NTS where SARs terminate (Fig.1C)d e t e c t e dar h y t h m i c
signalthatwasphaselockedtochangesintrachealpressure
(a measure of lung inﬂation) (Fig.2A and B). This signal
had a mean amplitude of 11.7±1.3pA (n=10). No
Figure 2. Rhythmic ATP release in the
NTS
A, representative raw data illustrating
records of the arterial blood pressure,
phrenic nerve activity, tracheal pressure,
null and ATP sensor currents. The sensors
were placed into the NTS area where slowly
adapting pulmonary stretch receptor
afferents terminate. ‘netATP’ trace
represents difference in sensor signal
between ATP and null sensors. B,a n
expanded portion of the same record
demonstrating rhythmic ATP release phase
locked to changes in tracheal pressure.
C, raw data illustrating records of the
arterial blood pressure, phrenic nerve
activity, tracheal pressure, null and ATP
sensor currents when the sensors are
placed into the commissural NTS. ABP,
arterial blood pressure; IPNA, integrated
phrenic nerve activity (arbitrary units).
such rhythmic signal was detected by the ‘null’ sensors
that lacked enzymes in the polymer coating or by the
ATP biosensors placed outside this circumscribed area
(Fig.2C). This rhythmic signal recorded by the ATP
biosensorswithintheNTSwasequivalenttoapeakchange
inATPconcentrationof61±8n M(n=10).Peakincrease
in ATP level was observed 60±16ms (n=10) after the
peak increase in tracheal pressure (see Fig.4B). There
was a strong correlation (R2 =0.81, P =0.014) between
the amplitude of the recorded rhythmic signal and the
sensitivity of the ATP biosensors. Given that ATP seems
to be released from a circumscribed area of the NTS it
is unlikely that the entire surface area of the biosensor is
in contact with the releasing tissue. This estimate of the
change in ATP concentration is therefore likely to be an
underestimate of the true change (see Methods).
Rhythmic ATP release in the NTS does not depend
upon inspiratory activity
To test whether the rhythmic ATP release depended
upon the central respiratory drive, central apnoea was
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induced by mechanical hyperventilation to reduce blood
and brain levels of PCO2 below the apnoeic threshold
(Fig. 3). Mechanical hyperventilation ﬁrst greatly reduced
the amplitude of the phrenic nerve bursts; however, the
rhythmicATPsignalwasenhanced(inlinewiththegreater
lung inﬂation) and remained phase locked to changes in
tracheal pressure (Fig. 3). Furthermore, the dependence
on lung inﬂation, as opposed to centrally generated
respiratory activity, was conﬁrmed by continuing hyper-
ventilation to the point where apnoea was induced, but
rhythmic ATP release, phase locked to changes in tracheal
pressure, remained (Fig. 3).
Rhythmic ATP release in the NTS is dependent upon
vagal nerve afferent input
To determine whether this rhythmic ATP release requires
vagalnerveinput,thenervewasexposedtoallowreversible
blockade of the conductance (including pulmonary SARs
conductance) by topical application of local anaesthetic.
After recording a control period of rhythmic ATP release,
lidocaine(1%insaline)wasappliedtotheipsilateralvagus
nerve. This treatmentimmediately increasedthe duration
of the phrenic nerve discharge to that typically observed
inavagotomizedanimalandalmostcompletelyabolished
therhythmicATPrelease(Fig.4).Afteraperiodofwashing
(10–15min)thenervewithsaline,fullrecoveryoftheATP
signal and phrenic nerve discharge pattern were achieved
(Fig. 4).
Rhythmic ATP release in the NTS is not affected by
the blockade of EAA receptors or activation
of GABA receptors
The EAA receptor antagonist kynurenic acid or GABA
were applied in high concentrations (5 and 100mM,
Figure 3. Rhythmic ATP release in the NTS does not depend upon central respiratory drive
Representative raw data showing recordings of the phrenic nerve activity, tracheal pressure and difference in
current between ATP and null sensors in basal conditions and during mechanical hyperventilation resulting in
central apnoea (arterial PCO2 and end-tidal CO2 below apnoeic threshold). IPNA, integrated phrenic nerve activity
(arbitrary units).
respectively) to the exposed dorsal surface of the brain-
stem. Both treatments resulted in a signiﬁcant alteration
of autonomic activity, as evident from the reduced
respiratory activity and marked changes (either decrease
evoked by GABA or increase evoked by kynurenic acid) in
blood pressure (Fig.5A). However, the amplitude of the
rhythmic ATP release phase-locked with lung inﬂation
cycle was unchanged (Fig.5B).
Electrical stimulation of the vagus nerve evokes ATP
release in the NTS
After cutting the vagus nerve (to eliminate rhythmic lung
inﬂation-induced ATP release in the NTS), its central
end was stimulated electrically to determine whether it
c o u l dt r i g g e rr e l e a s eo fA T P .T r a i n so fe l e c t r i c a ls t i m u l i
were delivered at a rate slightly higher than the ventilator
rate (Fig.5C) to determine whether sensor dynamics
and sensitivity were sufﬁcient to accurately follow rapid
phasic changes in ATP concentration. It was found that
electrical stimulation of the vagus nerve reliably evoked
ATP release in the NTS area where pulmonary SARs
terminate (Fig.5C).
Rhythmic glutamate release in the NTS: dependence
upon vagal nerve afferent input
Previous reports have presented strong evidence for a role
forglutamateinmediatingthetransmissionfromtheSARs
to the NTS second order relay neurones (Bonham et al.
1993; Zhang & Mifﬂin, 1995; Miyazaki et al. 1999). To
conﬁrm the role of glutamate, and compare release of
glutamateintheNTSduringlunginﬂationcyclewiththat
of ATP, we devised a glutamate biosensor (Fig.1A,s e e
Methods) and placed it within the NTS at the locations
w h e r ew eh a dp r e v i o u s l ys e e nr h y t h m i cA T Pr e l e a s e
(Fig.1B and C).
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A signal was recorded on the glutamate biosensors
(but not on the ‘null’ sensors) that was similar to that
detected by the ATP biosensors: rhythmic release phase
locked to changes of tracheal pressure (Fig.6A). The
amplitude of the signal was 8.8±0.8pA (n=6), and
this was equivalent to a rhythmic change in glutamate
concentration of 39.8±3.5nM (n=6) in magnitude.
Peak increase in glutamate level was observed 93±17ms
(n=6) after the peak increase in tracheal pressure. This
estimate of glutamate release is very likely an under-
estimate for the same reasons outlined above. However,
the amplitude of the recorded rhythmic signal correlated
verystrongly(R2 =0.76,P =0.005)withthesensitivityof
the glutamate biosensors determined in vitro.
To test the dependence of glutamate release in the
NTS on the vagal nerve input, we once again utilized
reversible blockade of this nerve by topical application
of lidocaine. Lidocaine (1% solution) application on the
cervical vagus nerve resulted in a signiﬁcant blockade of
the rhythmic glutamate release (Fig.6B–D)–t h ee f f e c t
similar to that observed when ATP release was studied
Figure 4. Rhythmic ATP release in the NTS is dependent upon vagal nerve afferent input
A, representative raw data showing recordings of the phrenic nerve activity, tracheal pressure and difference in
current between ATP and null sensors in basal conditions and during reversible blockade of the vagus nerve
conductance by topical application of lidocaine (1% in saline). B, results are presented as the averages of the
netATP trace for 60 inﬂation–deﬂation cycles triggered from the peak of tracheal pressure increase before, during
and after lidocaine application on the vagus nerve (ipsilateral to the ATP sensor placement in the NTS). C, mean
amplitudes of the ATP signal before, during and after blockade of the vagus nerve conductance (n = 6). IPNA,
integrated phrenic nerve activity (arbitrary units).
(Fig. 4). Kynurenic acid (5mM; n=3, data not shown) or
P2receptorantagonistPPADS(1or10mM;n=4,Fig.6D)
applied on the dorsal surface of the brainstem had no
effect on the amplitude of rhythmic glutamate release in
the NTS.
ATP induces an increase in discharge of the NTS
second order relay neurones that receive SARs input
The responses of 12 NTS pump cells were tested
to ionophoretical application of ATP. ATP induced a
signiﬁcant (on average by ∼60%) increase in ﬁring
frequencyof every singlepump cell recorded(Fig.7A–C).
This increase in the discharge frequency in response to
ATP was observed only during the active phase of the
neurone; ﬁring was not induced by ATP during the
phase of the inspiratory inhibition of the pump cells
(Fig.7A). All Iβ neurones tested (n=4) also increased
theirﬁringinresponsetoATPbythesameextent(Fig.7C).
In contrast, none of the recorded Iα neurones (n=8)
and deﬂation-sensitive neurones (n=6) responded to
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microionophoretic application of ATP with changes in
their discharge (Fig.7C).
ATP application into the NTS evokes apnoea
In six anaesthetized and artiﬁcially ventilated animals,
microinjection of ATP (20mM,5 0n l )i n t ot h eN T Ss i t e
where SARs terminate induced immediate and prolonged
cessation of the respiratory activity (Fig.7D). A period of
ATP-induced apnoea lasted 39±4s.
Both P2 and glutamate receptors mediate excitation
of the second order relay neurones
As a ﬁnal test of the respective roles of glutamate
and ATP release in the NTS, the effects of EAA and
P2 receptor antagonists on ﬁring of the second order
relay pump neurones were examined (Fig. 8). To reduce
the spread of the drugs to neighbouring neurones, the
ionophoretic currents were kept as low as possible. It
Figure 5. ATP release in the NTS is not affected by the blockade of excitatory amino acid receptors or
activation of GABA receptors and can be evoked by electrical stimulation of the vagus nerve
A, raw data showing recordings of the arterial blood pressure, phrenic nerve activity, tracheal pressure and
difference in current between ATP and null sensors in basal conditions and during applications of EAA receptor
antagonist kynurenic acid (KYN) or GABA on the exposed dorsal surface of the brainstem. B, mean amplitudes of
the rhythmic ATP signal following applications of kynurenic acid or GABA on the dorsal surface of the brainstem
(n = 4). C, electrical stimulation of the vagus nerve triggers release of ATP in the NTS. Arrows indicate the onset
of 250 ms stimulation period. ABP, arterial blood pressure; IPNA, integrated phrenic nerve activity (arbitrary units).
wasfoundthatPPADS(100μM,50nA),suramin(20mM,
50nA) as well as kynurenic acid (100mM, 50nA) reduced
discharge of the NTS pump cells by 16% (P <0.001,
n=16), 22% (P <0.0001, n=16) and 28% (P <0.0001,
n=15), respectively (Fig.8C). In contrast, discharge of
Iα neurones was not affected by either PPADS (n=4)
or suramin (n=5), although kynurenic acid had a
small but signiﬁcant effect, reducing ﬁring of Iα cells
by 10% (P <0.01, n=5, Fig.8C). In a further nine
pump neurones, the effects of suramin and kynurenic
acid applied either individually or in combination were
studied. Suramin and kynurenic acid applied using a
smaller current of 25nA reduced ﬁring of the pump cells
by 13% (P <0.001, n=9) and 14% (P <0.001, n=9),
respectively (Fig. 8B and D). When these agents were
appliedsimultaneouslypumpcell’sdischargewasreduced
by 37% (P <0.0001) (Fig.8D) .H o w e v e r ,t h ed e c r e a s ei n
dischargeduringsimultaneousapplicationofsuraminand
kynurenic acid was not signiﬁcantly greater (P =0.078)
than the sum of the effects of each drug applied alone,
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suggesting an additive action between ATP and glutamate
on the activity of the NTS pump cells. (In three
neurones at the end of the recordings, suramin
and kynurenic acid were applied simultaneously using
Figure 6. Rhythmic glutamate release in the NTS. Dependence upon vagal nerve afferent input
A, raw data illustrating records of the arterial blood pressure, phrenic nerve activity, tracheal pressure, null and
glutamate sensor currents. The sensors were placed into the NTS area where slowly adapting pulmonary stretch
receptor afferents terminate. ‘netGlu’ trace represents difference in sensor signal between glutamate and null
sensors. B, raw data showing recordings of the tracheal pressure and difference in current between glutamate
and null sensors in basal conditions and during reversible blockade of the vagus nerve conductance by topical
application of lidocaine (1% in saline). C, results are presented as the averages of the netGlu trace for 60
inﬂation–deﬂation cycles triggered from the peak of tracheal pressure increase before, during and after lidocaine
application on the vagus nerve (ipsilateral to the glutamate sensor placement in the NTS). D, black columns: mean
amplitudes of the rhythmic glutamate signal before, during and after blockade of the vagus nerve conductance
(n = 5). Grey columns: mean amplitudes of the rhythmic glutamate signal in basal conditions and following
application of pyridoxal-5 -phosphate-6-azophenyl-2 ,4 -disulphonic acid (PPADS) on the exposed dorsal surface
of the brainstem (n = 4). ABP, arterial blood pressure. IPNA, integrated phrenic nerve activity (arbitrary units).
50nA currents (Fig.8B). Since these applications were
tested in 3 out of 9 cells we were unable to
compare the effects observed with the rest of the
data.)
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Discussion
The data obtained in the present study suggest that ATP
and glutamate are released in the NTS from the central
terminals of the slowly adapting lung stretch receptor
afferents, activate the second-order relay neurones and
hence mediate the Breuer–Hering inﬂation reﬂex.
Figure 7. ATP induces an increase in discharge of the NTS pump cells and evokes central apnoea when
injected into the NTS
A, raw data illustrating the response of the NTS pump neurone to microionophoretic application of ATP (20 mM).
B, time-condensed record of the ﬁring rate of the same neurone. Black horizontal bar indicates timing of ATP
application. C, summary data of peak change in discharge of the NTS rhythmic neurones induced by micro-
ionophoretic application of ATP (20 mM, 50 nA). Numbers of neurones in each group are given in the main text
(see Results). D, raw data illustrating the effect of ATP (20 mM, 50 nl) on the respiratory activity and arterial blood
pressure when microinjected unilaterally into the NTS site where SARs terminate. ABP, arterial blood pressure. ff,
instantaneous ﬁring frequency. IPNA, integrated phrenic nerve activity (arbitrary units).
Technical considerations
In our previous studies in anaesthetized and conscious
rats and rabbits we used biosensors to measure changes in
ATP and adenosine concentrations in the hypothalamus
and the brainstem (Gourine et al. 2002, 2005a,b, 2007;
Dale et al. 2002). These studies described relatively slow
(developing over several seconds and minutes) changes in
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analyte concentrations during physiological responses to
systemic hypoxia, hypercapnia or inﬂammation. Here, we
havemeasuredrapidrhythmicpeaksofATPandglutamate
releaseattheﬁrstcentralsynapsesofpulmonarymechano-
afferents.
Biosensors placed into the brain tissue in vivo are
prone to non-speciﬁc detection of either mechanical
Figure 8. Blockade of ATP receptors and/or excitatory amino acid receptors decreases discharge of the
NTS pump cells
A, raw data illustrating the response of the NTS pump neurone to microionophoretic application of P2 receptor
antagonist suramin (20 mM) or EAA blocker kynurenic acid (KYN, 100 mM). B, time-condensed record of the ﬁring
rate of the same neurone illustrating its responses to suramin (20 mM) and kynurenic acid (100 mM) applied using
the currents shown. Black horizontal bars indicate timings of suramin or kynurenic acid applications. C, summary
data of changes in discharge of the NTS pump cells and Iα neurones evoked by microionophoretic applications of
PPADS (100 μM, 50 nA), suramin (50 nA) or kynurenic acid (50 nA). Numbers of neurones in each group are given
in the main text (see Results). D, summary data of changes in discharge of the NTS pump neurones (n = 9) evoked
by suramin and kynurenic acid applied either individually or in combination.
(movement of the brain due to the ventilation of the
lungs) or chemical (release of some electroactive inter-
ferents) artifacts. This is especially important when we
record relatively small signals like those detected in the
presentstudy.Thesesignalsappeartobegenuinerhythmic
changes in ATP and glutamate levels for several reasons.
First, in each experiment, null sensors lacking essential
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detectingenzymesinthepolymerlayerwereplacedintoan
equivalentpositiononthecontralateralsiteofthemedulla.
No rhythmic signal was detected by these control sensors.
Second, rhythmic signals were not detected by either
ATP or glutamate biosensors when placed outside the
circumscribed NTS area where SARs terminate (Bonham
& McCrimmon, 1990). These two observations eliminate
severaltypesofpossibleartifacts,e.g.thatthesensorswere:
(i)pickingupaﬁeldpotential;(ii)measuringnon-speciﬁc
electroactive interferents; or (iii) the signals were due to
mechanical movement of the tissue. Third, there was a
strong correlation between the amplitude of the rhythmic
signal and the sensitivity of the biosensors.
This dependence of signal amplitude on biosensor
sensitivity strongly indicates that the rhythmic signals
recorded were indeed due to rhythmic release of ATP
or glutamate. By extension, these results indicate that
the speed of the biosensor response is sufﬁcient to
rapidly follow rhythmic changes in ATP or glutamate
concentrations occurring with the cycle length of ∼1s.
This is not obvious from the presented calibration
curve (Fig.1A), since change-over of the solution in the
calibration chamber was not a step change and it would
take a few seconds for glutamate to reach the desired
concentration(notethatthesensorrespondsimmediately
as the analyte solution is entering the chamber).
Although the evidence obtained leaves little doubt
that the signals detected by the ATP and glutamate
sensors in the NTS represent rhythmic changes in ATP
and glutamate levels, the values of peak ATP and
glutamatereleasesreportedabovearelikelytosubstantially
underestimate the actual amounts released. First, as
discussed above, conversion of sensor current to changes
in analyte concentrations assumes that the entire surface
of the sensor is in contact with the sites releasing
ATP and glutamate. This is unlikely to be the case.
Second, the measured rhythmic changes in ATP and
glutamate concentrations may represent only a small
fraction of what is actually released due to high activities
of ectonucleotidases rapidly breaking down ATP and
extremely powerful glutamate re-uptake mechanisms.
Nevertheless, values of peak ATP and glutamate releases
provide important information regarding changes in ATP
and glutamate levels in the vicinity of the sensor and
allow determination of the effect of a given treatment (i.e.
blockadeofthevagusnerveconductance)ontheirrelease.
The glutamate signal reaches a peak signiﬁcantly
later following the peak increase in tracheal pressure
(93±17ms, n=6) than the ATP signal (60±16ms,
n=10, P <0.05). This difference in dynamics could
arise from three possible sources: (i) differences in ATP
and glutamate biosensor dynamics; (ii) differences in the
dynamicsofATPandglutamaterelease;or(iii)differences
in the speed of ATP and glutamate diffusion from their
sites of release to the biosensor. As the dynamics of
the ATP and glutamate biosensors are very similar, we
think the ﬁrst explanation is unlikely. Since our evidence
suggests that ATP and glutamate are both released from
the SARs central terminals, we think that the second
explanation is also unlikely. Instead we favour the notion
that diffusion of ATP and glutamate through the neural
tissue differs. ATP neurotransmission is terminated by
the actions of ectoATPases that break down ATP to ADP
and downstream purines (Robson et al. 2006). Glutamate
transmission is terminated by diffusion away from the
synaptic cleft and uptake through high-afﬁnity trans-
porters (Danbolt, 2001). The dynamics of these processes
and the distribution of transporters and ectoATPases are
likely to be sufﬁciently different to explain the distinctive
dynamics of the ATP and glutamate signals.
Source of rhythmic ATP and glutamate release
in the NTS
The ATP and glutamate microelectrode biosensors
detected rhythmic signals in the vicinity of the SAR
terminals phase-locked to changes in tracheal pressure.
This observation does not unambiguously indicate that
the central terminals of SARs release ATP and glutamate;
they could be released instead by the populations of
second-order relay (e.g. pump cells) or other NTS
neurones with rhythmic respiratory-related discharge
(e.g. Iβ neurones). Three pieces of evidence make these
alternatives unlikely.
First, rhythmic ATP release shows independence of the
centralrespiratoryactivity–theamplitudeoftherecorded
signal was not diminished when central apnoea was
induced by mechanical hyperventilation (which would
also reduce or abolish the activities of the NTS respiratory
neurones). Second, rhythmic ATP and glutamate release
requires vagus nerve input – the signals were reversibly
abolishedduringblockadeofthevagusnerveconductance
by topical application of the local anaesthetic. Third, the
amplitudes of the rhythmic ATP and glutamate signals
werenotaffectedbyhighconcentrationsofkynurenicacid
or GABA applied on the dorsal surface of the brainstem
– both of these treatments are expected to signiﬁcantly
depress neuronal activities in the dorsal medullary
structures, including the NTS (note profound changes
in blood pressure and respiratory activity following
kynurenic acid or GABA applications, Fig.5A). Our data
therefore suggest very strongly that SARs indeed release
ATP and glutamate from their central terminals in the
NTS.
Roles of ATP and glutamate in mediating the
Breuer–Hering inﬂation reﬂex
The data obtained in the current study suggest that both
ATP and glutamate mediate the Breuer–Hering inﬂation
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reﬂex at the central terminals of the SARs. Unilateral
microinjection of ATP into the NTS site of release
produced central apnoea – this mimics the effect of lung
inﬂation on breathing. Similar effects of ATP applications
into the intermediate NTS have been described in
awake rats and in in situ working heart–brainstem rat
preparations (Antunes et al. 2005a,b). EAA agonists
applied into the same NTS region also cause apnoea and
thus similarly mimic the effect of lung inﬂation (Bonham
& McCrimmon, 1990; Bonham et al. 1993).
If ATP release mediates excitation from the SARs, it
should excite the postsynaptic relay neurones – the pump
cells. Indeed, like DL-homocysteic acid (Bonham et al.
1993),applicationofATPinducedasigniﬁcantincreasein
ﬁringofallNTSpumpcellstested.Interestingly,otherNTS
neurones (Iβ cells) known to receive monosynaptic input
from the SARs (Backman et al. 1984) were also excited by
ATP, whilst other subpopulations of NTS respiratory cells
(e.g. Iα neurones) were not affected. Thus, it appears that
inthecircumscribedNTSareawhereSARsterminate,only
thoseneuronesthatreceiveinputsfromtheSARsrespond
to ATP with increases in their discharge.
Naturally, ATP may have either pre- or(and) post-
synaptic actions. It is possible that ATP released from
the central terminals of the SARs is acting presynaptically
to facilitate release of glutamate from the same/adjacent
terminals. This possibility is supported by the evidence
obtained previously in in vitro experiments showing
ATP-induced potentiation of glutamate release from
the myelinated afferent terminals in the NTS (Kato &
Shigetomi,2001;Jinetal.2004).However,inthisstudywe
found that application of P2 receptor antagonist PPADS
in a high concentration on the dorsal surface of the brain-
stemhadnoeffectontheamplitudeofrhythmicglutamate
release in the NTS. These data suggest that ATP released
from the central terminals of the SARs does not facilitate
releaseofglutamatebypresynapticP2receptoractivation.
Blockade of P2 receptors signiﬁcantly reduced the
rhythmic discharge of the NTS pump cells – an effect
similar to that previously reported for EAA receptor
antagonists(Bonhametal.1993;Miyazakietal.1999).We
conﬁrmed these earlier observations and demonstrated
a signiﬁcant reduction in pump cell ﬁring during
application of kynurenic acid. Previously Miyazaki et al.
(1999) reported almost complete suppression of pump
cells ﬁring by CNQX. In our experiments only ∼30%
inhibitionwasachievedwhenkynurenicacidwasapplied.
However, since we were concerned about the spread of
the drugs to the neighbouring neurones, the ionophoretic
currents were kept as low as possible. When suramin was
applied simultaneously with kynurenic acid the resulting
reductioninpumpcellsﬁringwasnotsigniﬁcantlygreater
than the sum of the effects of each drug applied alone.
This suggests an additive action between the ATP- and
glutamate-mediated excitation of the pump neurones.
AlthoughourresultssuggestverystronglythatATPand
glutamate are released from the central terminals of the
SARs to mediate the Breuer–Hering inﬂation reﬂex, there
aresomedatathataredifﬁculttoreconcilewithourresults.
Kato et al. (2004) demonstrated in rabbits that injection
of PPADS into the NTS attenuated respiratory responses
evoked by low-frequency stimulation of the vagus nerve
(mimicking lung deﬂation), while responses triggered by
high-frequency stimulations (mimicking lung inﬂation)
wereunaffectedbyPPADSapplication.Thisinconsistency
betweentheseresultsandoursmayarisefromthemethod
of stimulation, and the precise location and doses of
PPADS that were used. For example, Kato et al. (2004)
injected PPADS at a position slightly caudal (obex level,
1.5mm lateral) from that in our experiments. In any case,
the results by Kato et al. (2004) suggest that ATP may also
mediate transmission in the lung deﬂation reﬂex pathway
– averyinterestingpossibilityasthe respiratoryresponses
to lung inﬂation or deﬂation have long been known to
utilize distinct afferent pathways (Head, 1889).
Glutamate- and ATP-mediated transmission
in central afferent processing
A substantial body of literature demonstrates the
importance of glutamatergic transmission in mediating
several visceral afferent reﬂexes, including arterial
baroreﬂexes (Guyenet et al. 1987; Kubo & Kihara, 1991;
Gordon & Leone, 1991), arterial chemoreﬂexes (Zhang
& Mifﬂin, 1993, 1995; Vardhan et al. 1993; Mizusawa
et al. 1994) as well as pulmonary stretch receptor reﬂexes
(Bonham et al. 1993; Miyazaki et al. 1999).
ATP mediates neurotransmission of the
parasympathetic (but not respiratory) component
of the chemoreceptor reﬂex (Paton et al. 2002). More
recently, in the commissural NTS, both glutamate and
ATP were proposed to play a role in neurotransmission
of the sympathoexcitatory component of the arterial
chemoreﬂex (Braga et al. 2007). Our ﬁndings now show
that ATP signalling and cotransmission with glutamate
are even more pervasive in central autonomic functions
than had been previously realized.
Although, the data indicate that ATP and glutamate
are released in the NTS from the SARs central terminals,
the particular details of this co-release remain unclear. A
novel vesicular nucleotide transporter has been recently
identiﬁed (Sawada et al. 2008); however, we do not know
whetherATPandglutamatearepackedandreleasedwithin
the same vesicles or even from the same nerve terminals.
SARs are heterogeneous in terms of the ﬁring frequency,
threshold, and the ﬁring proﬁle (Sant’Ambrogio, 1982;
Widdicombe, 2001). It remains to be determined whether
different subsets of SARs release either ATP, glutamate, or
both transmitters.
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ATP-mediated purinergic signalling in afferent control
of breathing
This study contributes to an increasing body of
literature indicating that ATP-mediated signalling plays
a fundamental role in the mechanisms controlling
breathing. In the periphery, in response to a decrease in
PO2 (hypoxia) or an increase in PCO2/[H+] (hypercapnia),
chemosensitiveglomuscellsofthecarotidbody(themain
peripheral chemosensitive site) release ATP to activate
chemoafferent ﬁbres of the carotid sinus nerve which
transmit this information to the brainstem respiratory
centres (Zhang et al. 2000; Rong et al. 2003; Zhang
& Nurse, 2004). In the ventrolateral medulla, ATP is
released following CO2/H+-induced activation of central
chemoreceptors and acts within the respiratory network
to evoke physiologically relevant increases in ventilation
(Gourine, 2005; Gourine et al. 2005b). Thus, it emerges
that ATP acts as a common mediator of peripheral and
central chemosensory transduction and also contributes
toneurotransmissionattheﬁrstcentralsynapseofthekey
respiratory reﬂex – the Breuer–Hering inﬂation reﬂex.
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